Description
AUTOMATED BLOOD CULTURE SYSTEM AND REAGENTS
First action · last action
2025-10-01 · 2025-10-01
Transactions
1
First transaction's obligation
$278,149
Base + all options value (sum of deltas)
$278,149
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79722D0030
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-10-01+$278,149= $278,149
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-10-01 | +$278,149 | $278,149 | AUTOMATED BLOOD CULTURE SYSTEM AND REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under 6630 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126N0254 | BECKMAN COULTER, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $140,768 | FY2026 |
| 36C26126N0135 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $37,831 | FY2026 |
| 36C26126N0078 | ORTHO-CLINICAL DIAGNOSTICS, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $154,375 | FY2026 |
| 36C26125F0441 | AGILENT TECHNOLOGIES INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $18,574 | FY2025 |
| 36C26125P0217 | SYSMEX AMERICA, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $19,195 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26126F0020_3600_36F79722D0030_3600 · retrieved 2026-09-26.